JP2014510704A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014510704A5 JP2014510704A5 JP2013546310A JP2013546310A JP2014510704A5 JP 2014510704 A5 JP2014510704 A5 JP 2014510704A5 JP 2013546310 A JP2013546310 A JP 2013546310A JP 2013546310 A JP2013546310 A JP 2013546310A JP 2014510704 A5 JP2014510704 A5 JP 2014510704A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical tablet
- tablet
- pharmaceutical
- drug
- tablet according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061424967P | 2010-12-20 | 2010-12-20 | |
| US61/424,967 | 2010-12-20 | ||
| PCT/US2011/066021 WO2012088033A2 (en) | 2010-12-20 | 2011-12-20 | Novel pharmaceutical composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017007796A Division JP2017137299A (ja) | 2010-12-20 | 2017-01-19 | 新規医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014510704A JP2014510704A (ja) | 2014-05-01 |
| JP2014510704A5 true JP2014510704A5 (cg-RX-API-DMAC7.html) | 2015-02-05 |
| JP6126014B2 JP6126014B2 (ja) | 2017-05-10 |
Family
ID=46314827
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013546310A Active JP6126014B2 (ja) | 2010-12-20 | 2011-12-20 | 新規医薬組成物 |
| JP2017007796A Withdrawn JP2017137299A (ja) | 2010-12-20 | 2017-01-19 | 新規医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017007796A Withdrawn JP2017137299A (ja) | 2010-12-20 | 2017-01-19 | 新規医薬組成物 |
Country Status (38)
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI505828B (zh) | 2010-12-20 | 2015-11-01 | 葛蘭素史克智慧財產（第二）有限公司 | 新穎醫藥組成物 |
| LT2884979T (lt) | 2012-08-17 | 2019-09-10 | F. Hoffmann-La Roche Ag | Kombinuoti melanomos gydymo būdai, apimantys kobimetinibo ir vemurafenibo skyrimą |
| EA028246B1 (ru) * | 2012-11-30 | 2017-10-31 | ГЛЭКСОСМИТКЛАЙН ЭлЭлСи | Фармацевтическая композиция |
| WO2015019125A1 (en) * | 2013-08-05 | 2015-02-12 | Societe De Developpement Et De Recherche Industrielle | Molecular targets for the treatment of wounds, in particular chronic wounds |
| CN103819471A (zh) * | 2013-11-25 | 2014-05-28 | 镇江圣安医药有限公司 | 吡啶并(4,3-d)嘧啶-1（2H）-基苯基乙酰胺的衍生物及其应用 |
| CN104918937B (zh) * | 2013-12-06 | 2016-09-14 | 杭州普晒医药科技有限公司 | 曲美替尼及其溶剂化物的晶型、其制备方法、含有它们的药物组合物及其用途 |
| EP2913048A1 (en) * | 2014-02-27 | 2015-09-02 | ratiopharm GmbH | Pharmaceutical composition comprising trametinib |
| WO2016126012A1 (en) * | 2015-02-05 | 2016-08-11 | Boryung Pharmaceutical Co., Ltd | Tablet and method of preparing the same |
| KR101545268B1 (ko) | 2015-02-05 | 2015-08-20 | 보령제약 주식회사 | 정제 및 이의 제조방법 |
| US20170020880A1 (en) * | 2015-07-22 | 2017-01-26 | Hetero Research Foundation | Pharmaceutical compositions of trametinib |
| EP4613333A3 (en) | 2016-08-10 | 2025-10-29 | F. Hoffmann-La Roche AG | Pharmaceutical compositions comprising akt protein kinase inhibitors |
| RU2627692C1 (ru) | 2016-10-10 | 2017-08-10 | Закрытое акционерное общество "Р-Фарм" (ЗАО "Р-Фарм") | N-{ 3-[3-циклопропил-5-(2-фторо-4-иодофениламино)-6,8-диметил-2,4,7-триоксо-3,4,6,7-тетрагидро-2Н-пиридо[4,3-d]пиримидин-1-ил]-фенил} -циклопропанкарбоксамида диметилсульфоксида сольват в качестве ингибитора МЕК1/2 |
| TW201818936A (zh) | 2016-11-25 | 2018-06-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 一種吡啶酮類衍生物醫藥組成物及其製備方法 |
| DK3618875T3 (da) | 2017-05-02 | 2023-07-10 | Novartis Ag | Kombinationsterapi omfattende en raf-inhibitor og trametinib |
| KR102881316B1 (ko) | 2019-05-13 | 2025-11-05 | 노파르티스 아게 | 암 치료를 위한 raf 억제제로서의 n-(3-(2-(2-하이드록시에톡시)-6-모르폴리노피리딘-4-일)-4-메틸페닐)-2 (트리플루오로메틸)이소니코틴아미드의 새로운 결정질 형태 |
| CN114340670A (zh) | 2019-07-11 | 2022-04-12 | 普拉克西斯精密药物股份有限公司 | T-型钙通道调节剂的制剂及其使用方法 |
| CA3149796A1 (en) | 2019-08-02 | 2021-02-11 | Onehealthcompany, Inc. | Anti-cancer agents for the treatment of canine cancers |
| RU2749719C1 (ru) * | 2020-10-08 | 2021-06-16 | Нестерук Владимир Викторович | Препарат для лечения анемии, связанной с хроническим заболеванием почек, и способ его получения |
| EP4444299A1 (en) | 2021-12-06 | 2024-10-16 | My Personal Therapeutics Ltd | A combination treatment for cancer |
| WO2024171019A1 (en) * | 2023-02-13 | 2024-08-22 | Alembic Pharmaceuticals Limited | Pharmaceutical composition of trametinib and process of preparation thereof |
| WO2025132408A2 (en) | 2023-12-21 | 2025-06-26 | Synthon B.V. | Solvates of trametinib |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61205257A (ja) * | 1985-03-08 | 1986-09-11 | Ishihara Sangyo Kaisha Ltd | ベンゾイルウレア系化合物、その製法及びそれを含有する抗ガン剤 |
| US4727077A (en) | 1985-02-20 | 1988-02-23 | Ishihara Sangyo Kaisha Ltd. | Benzoyl urea compounds, process for their production, and antitumorous compositions containing them |
| US5559235A (en) | 1991-10-29 | 1996-09-24 | Glaxo Wellcome Inc. | Water soluble camptothecin derivatives |
| US5342947A (en) | 1992-10-09 | 1994-08-30 | Glaxo Inc. | Preparation of water soluble camptothecin derivatives |
| US5681835A (en) | 1994-04-25 | 1997-10-28 | Glaxo Wellcome Inc. | Non-steroidal ligands for the estrogen receptor |
| US5491237A (en) | 1994-05-03 | 1996-02-13 | Glaxo Wellcome Inc. | Intermediates in pharmaceutical camptothecin preparation |
| GB9716557D0 (en) | 1997-08-06 | 1997-10-08 | Glaxo Group Ltd | Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity |
| US6825180B2 (en) | 2001-05-18 | 2004-11-30 | Cell Therapeutics, Inc. | Pyridopyrimidine compounds and their uses |
| RS50569B (sr) * | 2004-06-11 | 2010-05-07 | Japan Tobacco Inc. | Derivati 5-amino-2,4,7-triokso-3,4,7,8-tetrahidro-2h-pirido (2,3-d)pirimidina i slična jedinjenja za lečenje raka |
| US7378423B2 (en) * | 2004-06-11 | 2008-05-27 | Japan Tobacco Inc. | Pyrimidine compound and medical use thereof |
| WO2008048469A2 (en) * | 2006-10-13 | 2008-04-24 | Actavis Group Pct Hf | Controlled-release coated dosage forms containing galantamine |
| WO2008060890A2 (en) * | 2006-11-09 | 2008-05-22 | Gilead Colorado, Inc. | Darusentan oral dosage form |
| JO2985B1 (ar) * | 2006-12-20 | 2016-09-05 | Takeda Pharmaceuticals Co | مثبطات كينازmapk/erk |
| UY30892A1 (es) | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | Inhibidores de la actividad akt |
| ECSP077628A (es) * | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
| JP5479337B2 (ja) * | 2007-07-30 | 2014-04-23 | アルディア バイオサイエンス，インク． | Ｍｅｋ阻害剤およびｒａｆキナーゼ阻害剤の組み合わせ、ならびにその使用 |
| WO2009042803A1 (en) * | 2007-09-25 | 2009-04-02 | Teva Pharmaceutical Industries Ltd. | Imatinib compositions |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| CN101878218B (zh) | 2008-07-08 | 2013-01-02 | 浙江贝达药业有限公司 | 埃克替尼盐酸盐及其制备方法、晶型、药物组合物和用途 |
| ES2527625T3 (es) | 2009-09-23 | 2015-01-27 | Glaxosmithkline Llc | Combinación farmacéutica |
| SG179144A1 (en) | 2009-09-23 | 2012-05-30 | Glaxosmithkline Llc | Combination |
| AU2010298020B8 (en) | 2009-09-28 | 2013-10-10 | Glaxosmithkline Llc | Combination |
| PL3560498T3 (pl) * | 2009-10-16 | 2022-12-12 | Novartis Ag | Kombinacja zawierająca inhibitor mek i inhibitor b-raf |
| BR112012011677A8 (pt) | 2009-11-17 | 2018-06-12 | Glaxosmithkline Llc | Combinação, kit de combinação e uso de uma combinação |
| EP2608790A4 (en) | 2010-08-26 | 2014-04-02 | Glaxosmithkline Llc | PHARMACEUTICAL COMBINATION OF A VEGFR-INHIBITOR AND A MEK-INHIBITOR FOR THE TREATMENT OF CANCER |
| TWI505828B (zh) | 2010-12-20 | 2015-11-01 | 葛蘭素史克智慧財產（第二）有限公司 | 新穎醫藥組成物 |
| US8977217B1 (en) | 2013-02-20 | 2015-03-10 | Triquint Semiconductor, Inc. | Switching device with negative bias circuit |
| CZ2015278A3 (cs) | 2015-04-24 | 2016-11-02 | Zentiva, K.S. | Krystalické formy trametinibu |
-
2011
- 2011-12-16 TW TW100146692A patent/TWI505828B/zh active
- 2011-12-18 JO JOP/2011/0385A patent/JO3594B1/ar active
- 2011-12-19 AR ARP110104773A patent/AR084102A1/es not_active Application Discontinuation
- 2011-12-19 UY UY0001033818A patent/UY33818A/es active IP Right Grant
- 2011-12-20 PH PH1/2013/501209A patent/PH12013501209A1/en unknown
- 2011-12-20 LT LTEP22209107.6T patent/LT4159205T/lt unknown
- 2011-12-20 SI SI201131918T patent/SI2654736T1/sl unknown
- 2011-12-20 AU AU2011349422A patent/AU2011349422B2/en active Active
- 2011-12-20 ES ES22209104T patent/ES2982775T3/es active Active
- 2011-12-20 DK DK11849974.8T patent/DK2654736T3/da active
- 2011-12-20 PE PE2013001442A patent/PE20140040A1/es active IP Right Grant
- 2011-12-20 EP EP20179788.3A patent/EP3808343A1/en active Pending
- 2011-12-20 FI FIEP22209107.6T patent/FI4159205T3/fi active
- 2011-12-20 HR HRP20240564TT patent/HRP20240564T1/hr unknown
- 2011-12-20 DK DK22209104.3T patent/DK4159204T3/da active
- 2011-12-20 MY MYPI2013701038A patent/MY170501A/en unknown
- 2011-12-20 US US13/330,949 patent/US8580304B2/en active Active
- 2011-12-20 ES ES11849974T patent/ES2820536T3/es active Active
- 2011-12-20 ES ES22209107T patent/ES2985024T3/es active Active
- 2011-12-20 JP JP2013546310A patent/JP6126014B2/ja active Active
- 2011-12-20 PL PL22209104.3T patent/PL4159204T3/pl unknown
- 2011-12-20 PL PL22209107.6T patent/PL4159205T3/pl unknown
- 2011-12-20 KR KR1020137019029A patent/KR101911109B1/ko active Active
- 2011-12-20 SI SI201132109T patent/SI4159204T1/sl unknown
- 2011-12-20 CN CN201180066851.0A patent/CN103998041B/zh active Active
- 2011-12-20 SI SI201132108T patent/SI4159205T1/sl unknown
- 2011-12-20 MX MX2013007073A patent/MX2013007073A/es active IP Right Grant
- 2011-12-20 MA MA36106A patent/MA34883B1/fr unknown
- 2011-12-20 HR HRP20240563TT patent/HRP20240563T1/hr unknown
- 2011-12-20 RS RS20240518A patent/RS65496B1/sr unknown
- 2011-12-20 CA CA2822701A patent/CA2822701C/en active Active
- 2011-12-20 PT PT222091076T patent/PT4159205T/pt unknown
- 2011-12-20 PL PL11849974T patent/PL2654736T3/pl unknown
- 2011-12-20 EP EP22209104.3A patent/EP4159204B1/en active Active
- 2011-12-20 LT LTEP22209104.3T patent/LT4159204T/lt unknown
- 2011-12-20 UA UAA201309128A patent/UA113158C2/uk unknown
- 2011-12-20 LT LTEP11849974.8T patent/LT2654736T/lt unknown
- 2011-12-20 HU HUE22209107A patent/HUE066526T2/hu unknown
- 2011-12-20 HU HUE11849974A patent/HUE050788T2/hu unknown
- 2011-12-20 EP EP22209107.6A patent/EP4159205B1/en active Active
- 2011-12-20 HR HRP20201409TT patent/HRP20201409T1/hr unknown
- 2011-12-20 WO PCT/US2011/066021 patent/WO2012088033A2/en not_active Ceased
- 2011-12-20 EP EP11849974.8A patent/EP2654736B1/en not_active Revoked
- 2011-12-20 SG SG2013044037A patent/SG191054A1/en unknown
- 2011-12-20 PT PT118499748T patent/PT2654736T/pt unknown
- 2011-12-20 FI FIEP22209104.3T patent/FI4159204T3/fi active
- 2011-12-20 DK DK22209107.6T patent/DK4159205T3/da active
- 2011-12-20 US US13/991,705 patent/US20130266649A1/en not_active Abandoned
- 2011-12-20 RS RS20240519A patent/RS65497B1/sr unknown
- 2011-12-20 EA EA201390913A patent/EA025198B1/ru not_active IP Right Cessation
- 2011-12-20 BR BR112013015602-3A patent/BR112013015602B1/pt active IP Right Grant
- 2011-12-20 NZ NZ612157A patent/NZ612157A/en unknown
- 2011-12-20 PT PT222091043T patent/PT4159204T/pt unknown
- 2011-12-20 HU HUE22209104A patent/HUE066525T2/hu unknown
-
2013
- 2013-06-07 ZA ZA2013/04189A patent/ZA201304189B/en unknown
- 2013-06-10 IL IL226855A patent/IL226855A/en active IP Right Grant
- 2013-06-18 DO DO2013000138A patent/DOP2013000138A/es unknown
- 2013-06-18 CL CL2013001779A patent/CL2013001779A1/es unknown
- 2013-07-19 CR CR20130352A patent/CR20130352A/es unknown
- 2013-10-02 US US14/044,139 patent/US9271941B2/en active Active
- 2013-12-11 US US14/103,193 patent/US9155706B2/en active Active
- 2013-12-11 US US14/103,092 patent/US9399021B2/en active Active
-
2017
- 2017-01-19 JP JP2017007796A patent/JP2017137299A/ja not_active Withdrawn
-
2020
- 2020-09-24 CY CY20201100905T patent/CY1123376T1/el unknown
-
2021
- 2021-05-27 AR ARP210101433A patent/AR122185A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014510704A5 (cg-RX-API-DMAC7.html) | ||
| HRP20201409T1 (hr) | Novi farmaceutski pripravak | |
| JP6770946B2 (ja) | ２−フルオロ−ｎ−メチル−４−［７−（キノリン−６−イルメチル）イミダゾ［１，２−ｂ］［１，２，４］トリアジン−２−イル］ベンズアミドの錠剤 | |
| JP6122098B2 (ja) | オルメサルタンメドキソミルとロスバスタチンまたはその塩とを含む医薬組成物 | |
| JP6001763B2 (ja) | 低用量エンテカビルの経口投与製剤の製造方法 | |
| JP2015157851A5 (cg-RX-API-DMAC7.html) | ||
| KR20150079454A (ko) | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 | |
| CN107530292A (zh) | 瑞博西尼片剂 | |
| AU2007314282A2 (en) | Elvucitabine pharmaceutical compositions | |
| WO2012053785A3 (ko) | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 | |
| RU2014140177A (ru) | Фармацевтические антиретровирусные композиции | |
| CN105263479A (zh) | 调整释放制剂 | |
| JP6243351B2 (ja) | パーキンソン病の固定投与量薬剤組合せ治療 | |
| JP2018150384A (ja) | 口腔内崩壊錠及びその製造方法 | |
| TWI704918B (zh) | 含有細胞周期蛋白抑制劑的藥物製劑及其製備方法 | |
| CN102198108A (zh) | 一种盐酸西那卡塞片剂或胶囊制备工艺 | |
| CN102342940B (zh) | 制备抗结核病的组合的改良方法及由其制得的医药组合物 | |
| CA2925960A1 (en) | Pharmaceutical composition comprising capecitabine and cyclophosphamide | |
| WO2015085739A1 (zh) | 一种多层固体药物剂型 | |
| CN107080741A (zh) | 吡非尼酮缓释制剂及制备方法 | |
| WO2016204657A3 (ru) | Способ получения фармацевтической композиции адеметионина и его лекарственной формы | |
| CN105687157A (zh) | 一种盐酸左氧氟沙星胶囊及其制备方法 | |
| CN102675338A (zh) | 微粉化普拉格雷及其药用组合物 | |
| CN104546733B (zh) | 一种苯丙哌林掩味微丸 | |
| WO2013169218A1 (en) | Pharmaceutical compositions of s-etodolac |